WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Sees Significant Decrease in Short Interest

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was the recipient of a significant drop in short interest in October. As of October 15th, there was short interest totaling 11,170 shares, a drop of 71.0% from the September 30th total of 38,536 shares. Based on an average daily volume of 63,773 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.0% of the company’s shares are sold short.

WuXi Biologics (Cayman) Trading Down 1.8%

Shares of OTCMKTS:WXXWY opened at $11.52 on Friday. The firm’s fifty day moving average is $12.90 and its 200-day moving average is $10.20. WuXi Biologics has a 52 week low of $7.30 and a 52 week high of $14.80.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised WuXi Biologics (Cayman) to a “hold” rating in a research note on Friday, August 28th. One equities research analyst has rated the stock with a Hold rating. According to MarketBeat.com, the company currently has an average rating of “Hold”.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Inc is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company works with pharmaceutical and biotechnology companies to support the discovery, development and commercial manufacturing of therapies, helping customers advance drug candidates from early research through clinical and commercial production.

Its capabilities include antibody and recombinant protein development, cell-line development, process development, clinical trial material production and large-scale biomanufacturing.